About Reinnervate
Reinnervate is a company based in Sedgefield (United Kingdom) founded in 2002 was acquired by ReproCELL in August 2014.. Reinnervate has raised $2 million across 2 funding rounds from investors including ReproCELL, Parkwalk and NorthStar Education Institute. Reinnervate operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
- Headquarter Sedgefield, United Kingdom
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Reinnervate
Reinnervate has successfully raised a total of $2M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Last Round
-
First Round
First Round
(28 May 2010)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2010 | Amount | Seed - Reinnervate | Valuation |
investors |
|
| May, 2010 | Amount | Seed - Reinnervate | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Reinnervate
Reinnervate has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include ReproCELL, Parkwalk and NorthStar Education Institute. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Tech companies are invested in by Parkwalk venture capital firm.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Leading global supplier of iPS-derived cells, stem cell reagents, human biofluids, and 3D cell culture.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Reinnervate
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Reinnervate
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Reinnervate Comparisons
Competitors of Reinnervate
Reinnervate operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| domain | founded_year | HQ Location |
CRISPR-engineered cell and gene therapies are developed for research applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Reinnervate
When was Reinnervate founded?
Reinnervate was founded in 2002 and raised its 1st funding round 8 years after it was founded.
Where is Reinnervate located?
Reinnervate is headquartered in Sedgefield, United Kingdom. It is registered at Sedgefield, County Durham, United Kingdom.
Is Reinnervate a funded company?
Reinnervate is a funded company, having raised a total of $2M across 2 funding rounds to date. The company's 1st funding round was a Seed of $2M, raised on May 28, 2010.
What does Reinnervate do?
Reinnervate (a ReproCELL company), is a spin-out company from Durham University that offers the Alvetex 3D cell culture platform. The technology is based on the research performed by Prof. Stefan Przyborski who also serves as the companys CSO. Alvetex is a highly porous polystyrene scaffold that is engineered into a 200 micron thick membrane. The scaffold is presented in various ways including multi-welled plates and well inserts, for use with conventional culture plasticware and a novel medium perfusion system. Alvetex 3D cell culture enables scientist to grow tissue-like structures that better mimic in vivo biology than current 2D monolayer methods. The potential to improve the predictive nature of cell-based assays by combining 3D culture and iPSC-derived cell products is attracting a lot of interest in the drug development industry. Reinnervates products are currently used by researchers in over 300 universities and companies globally.
Who are the top competitors of Reinnervate?
Reinnervate's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.